Mahmoud A. Khaimi, MD | Loteprednol Reduces IOP, Medications After Canaloplasty

Loteprednol Reduces IOP, Medications After Canaloplasty

IOP remained reduced in patients given loteprednol etabonate suspension 0.5% after canaloplasty, with or without cataract surgery, according to a study. The retrospective chart review was conducted at Dean McGee Eye Institute, University of Oklahoma. Data were collected for 204 patients who underwent canaloplasty with or without cataract surgery, with 58 undergoing surgery in both eyes on separate days. Nearly 92% of eyes were diagnosed with primary open-angle glaucoma with or without nuclear sclerotic cataracts at the time of surgery.

Read the complete article here.

Related Content

NEI Grant

NEI Grant


Vision Research Receives $2.9 Million Boostat OU Health Sciences Center, Dean McGee Eye Institute See pages 20 and 21 from the i2E publication for exciting research news.